Published in Genomics on July 01, 1992
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis (2000) 1.30
Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics (2010) 1.15
IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J Clin Immunol (2008) 1.06
Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis (2008) 0.95
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer (2005) 0.91
Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut (1998) 0.89
Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women. J Bone Miner Metab (2006) 0.87
Stroke, IL-1ra, IL1RN, infection and outcome. Neurocrit Care (2014) 0.83
Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus. World J Diabetes (2014) 0.81
Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women. Ann Saudi Med (2010) 0.81
Unusual linkage patterns of ligands and their cognate receptors indicate a novel reason for non-random gene order in the human genome. BMC Evol Biol (2005) 0.80
Interleukin-1β (3953/4) C→T polymorphism increases the risk of chronic periodontitis in Asians: evidence from a meta-analysis of 20 case-control studies. Arch Med Sci (2015) 0.80
Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal ureaplasma urealyticum colonization in pregnant women. Infect Immun (2003) 0.78
Predisposition of genetic polymorphism with the risk of urolithiasis. Indian J Clin Biochem (2008) 0.78
Genetics of the bone response to bisphosphonate treatments. Clin Cases Miner Bone Metab (2009) 0.76
Study of interleukin-1 receptor antagonist (IL-1Ra) gene polymorphism in healthy individuals from Northern India. Indian J Clin Biochem (2004) 0.75
Interleukin-1 gene cluster variants in hemodialysis patients with end stage renal disease: An association and meta-analysis. Indian J Nephrol (2015) 0.75
Association of IL1 beta gene polymorphism and allograft functions in renal transplant recipients :a case control study from Kashmir Valley. BMC Nephrol (2017) 0.75
The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis. PLoS One (2016) 0.75
Chromosomal mapping of the human interleukin-1 receptor antagonist gene (IL-1RN) and isolation of specific YAC clones. Agents Actions (1993) 0.75
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1982) 5.95
A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (1983) 3.86
Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 3.44
Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med (1995) 3.38
The unactivated form of the first component of human complement, C1. Biochem J (1976) 3.12
An autosomal transcript in skeletal muscle with homology to dystrophin. Nature (1989) 2.91
Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein. Nature (1988) 2.88
Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today (1994) 2.81
The covalent-binding reaction of complement component C3. Biochem J (1981) 2.80
The complete amino acid sequence of human complement factor H. Biochem J (1988) 2.63
Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med (1984) 2.53
An adaptive response of E. coli to low levels of alkylating agent: comparison with previously characterised DNA repair pathways. Mol Gen Genet (1977) 2.45
Isolation and characterization of Escherichia coli K-12 mutants unable to induce the adaptive response to simple alkylating agents. J Bacteriol (1979) 2.39
Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med (1990) 2.29
The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins. Cell (1987) 2.23
Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child (2001) 2.07
Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer (1998) 2.06
Single nucleotide polymorphisms as tools in human genetics. Hum Mol Genet (2000) 2.05
Chromosomal localisation of the human homologues to the oncogenes erbA and B. EMBO J (1984) 2.02
The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37. Ann Hum Genet (1987) 2.00
Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol (1996) 2.00
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Chromosomal localization of human cellular homologues of two viral oncogenes. Nature (1982) 1.96
Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature (1990) 1.96
Simple repeat sequences on the human Y chromosome are equally polymorphic as their autosomal counterparts. Hum Genet (1992) 1.94
Purification and structural studies on the complement-system control protein beta 1H (Factor H). Biochem J (1982) 1.91
Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol (1999) 1.88
Stable length polymorphism of up to 260 kb at the tip of the short arm of human chromosome 16. Cell (1991) 1.87
Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement. J Clin Invest (1985) 1.86
Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (1993) 1.84
Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents. Mol Immunol (1979) 1.78
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods (2004) 1.78
Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78
Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med (2007) 1.78
Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin. Biochem J (1981) 1.78
The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement. Biochem J (1977) 1.78
A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res (1997) 1.73
Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol (1993) 1.68
Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutat Res (1991) 1.62
Chromosomal locations of the gene coding for the CD3 (T3) gamma subunit of the human and mouse CD3/T-cell antigen receptor complexes. Immunogenetics (1987) 1.60
Prenatal maternal blood pressure response to stress predicts birth weight and gestational age: a preliminary study. Am J Obstet Gynecol (1996) 1.59
Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression. Science (1973) 1.59
Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res (1995) 1.57
Complete sequence of human vinculin and assignment of the gene to chromosome 10. Proc Natl Acad Sci U S A (1990) 1.57
Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (1991) 1.53
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med (1989) 1.52
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2). Biochem J (1984) 1.51
A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. Structure (1997) 1.51
Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry (1997) 1.50
CYP2D6 genotyping and the association with lung cancer susceptibility. Pharmacogenetics (1994) 1.50
Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem J (1985) 1.49
Structure, organization, and regulation of the complement genes. Annu Rev Immunol (1988) 1.47
Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI. Int J Cancer (1986) 1.45
Three-dimensional structure of a complement control protein module in solution. J Mol Biol (1991) 1.44
Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3). Eur J Immunol (1986) 1.43
Pathways of mutagenesis and repair in Escherichia coli exposed to low levels of simple alkylating agents. J Bacteriol (1978) 1.43
Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma. FEBS Lett (1979) 1.42
Pattern of degradation of human complement fragment, C3b. FEBS Lett (1981) 1.42
Dynamic changes in HIV-1 quasispecies from azidothymidine (AZT)-treated patients. FASEB J (1992) 1.41
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet (1992) 1.41
Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q. Biochem J (1977) 1.40
Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med (1997) 1.40
Monoclonal antibodies against the complement control protein factor H (beta 1 H). Biosci Rep (1983) 1.40
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. J Virol (1992) 1.39
Structure and homology of human C1q receptor (collectin receptor). Immunology (1993) 1.37
Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res (1987) 1.37
Activation of the first component of human complement (C1) by antibody-antigen aggregates. Biochem J (1978) 1.36
Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. Biochem J (1991) 1.33
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun (1995) 1.32
Expression of complement factor H on the cell surface of the human monocytic cell line U937. Eur J Immunol (1985) 1.32
Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones. Biochem J (1987) 1.32
600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase. Biopolymers (1999) 1.32
Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase. Biochemistry (1999) 1.29
Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ (1992) 1.29
Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol (2000) 1.28
C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes. Biochem J (1979) 1.28
Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet (1993) 1.27
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses (1998) 1.27
A study of the structure of human complement component factor H by Fourier transform infrared spectroscopy and secondary structure averaging methods. Biochemistry (1988) 1.26
Sequence of human protein serine/threonine phosphatase 1 gamma and localization of the gene (PPP1CC) encoding it to chromosome bands 12q24.1-q24.2. Biochim Biophys Acta (1993) 1.25
Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet (1994) 1.25
A human T-cell antigen receptor beta chain gene maps to chromosome 7. EMBO J (1984) 1.24
Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem J (1985) 1.24
Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J (2010) 1.23
Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s. Biochem Soc Trans (1976) 1.21
Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther (1992) 1.21
Molecular features of CD34: a hemopoietic progenitor cell-associated molecule. Leukemia (1992) 1.21
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine (2002) 1.20
Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol (2000) 1.20
A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype. Cancer Res (1997) 1.19
Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet (1997) 1.19
Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system. Biochem J (1993) 1.19
Interaction of C1q receptor with lung surfactant protein A. Eur J Immunol (1992) 1.18
Large linkage analysis in 100 families with autosomal recessive spinal muscular atrophy (SMA) and 11 CEPH families using 15 polymorphic loci in the region 5q11.2-q13.3. Genomics (1994) 1.18
A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s. FEBS Lett (1977) 1.18